C92.Z0
Other myeloid leukemia not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Myeloid leukemia NEC with failed remission
- Myeloid leukemia NEC
Medical Intelligence & Overview
Myeloid leukemia not having achieved remission is a serious blood cancer characterized by the uncontrolled growth of abnormal myeloid cells in the bone marrow and blood. This condition is classified under ICD-10 code C92.Z0, indicating a type of myeloid leukemia that has not responded to treatment and remains active. It is a part of the broader category of leukemia, a group of cancers affecting the blood and bone marrow. When remission is not achieved, the disease continues to progress, making management more challenging and often requiring ongoing treatment strategies.
Causes & Symptoms
Clinical Causes: Genetic mutations in hematopoietic (blood-forming) stem cells Exposure to certain chemotherapy drugs or radiation Previous history of other blood disorders Environmental factors such as exposure to benzene or other chemicals Family history of leukemia or other blood cancers
Key Symptoms: Persistent fatigue and weakness Unexplained weight loss Frequent or severe infections Easy bruising or bleeding, such as bleeding gums or nosebleeds Bone and joint pain or tenderness Swelling of lymph nodes or spleen Paleness and shortness of breath
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC): to evaluate abnormal levels of blood cells Bone marrow aspiration and biopsy: to examine the types and quantities of cells present Cytogenetic and molecular tests: to identify genetic abnormalities associated with leukemia Flow cytometry: to determine the specific type of leukemia cells Additional imaging tests may be used to assess the spread or impact of the disease
Treatment Protocols: Chemotherapy: intensive drug regimens aimed at destroying leukemia cells Targeted therapy: medications designed to target specific genetic mutations or pathways Bone marrow or stem cell transplantation: replacing the diseased marrow with healthy cells, when feasible Supportive care: blood transfusions, antibiotics, and medications to manage symptoms and prevent complications Clinical trials: access to experimental treatments that may offer additional options
Clinical Advice & FAQs
Billing Guidance
Is C92.Z0 a billable ICD-10 code?
Yes, C92.Z0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.Z0?
Clinical documentation must specify the nature of Other myeloid leukemia not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference